A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression
- 1 June 2000
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 150 (2) , 295-298
- https://doi.org/10.1016/s0021-9150(99)00379-2
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.Journal of Clinical Investigation, 1998
- Mildly oxidized LDL induces an increased apolipoprotein J/paraoxonase ratio.Journal of Clinical Investigation, 1997
- Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.Journal of Clinical Investigation, 1997
- A variant of human paraoxonase/arylesterase (HUMPONA) gene is a risk factor for coronary artery disease.Journal of Clinical Investigation, 1995
- Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonaseAtherosclerosis, 1993
- Is paraoxonase related to atherosclerosisChemico-Biological Interactions, 1993
- Identification of a distinct human high‐density lipoprotein subspecies defined by a lipoprotein‐associated protein, K‐45European Journal of Biochemistry, 1993
- The molecular basis of the human serum paraoxonase activity polymorphismNature Genetics, 1993
- Paraoxonase prevents accumulation of lipoperoxides in low‐density lipoproteinFEBS Letters, 1991
- Purification and Biochemical Characterization of the Promoter-Specific Transcription Factor, Sp1Science, 1986